Administration Of Avermectin/milbemycin Compounds For The Treatment Of Ophthalmic Pathologies

Abstract

Administration of at least one compound of the family of the avermectins or of the family of the milbemycins, notably ivermectin, is useful for the treatment of ophthalmic pathologies, including ocular rosacea.


Claims
Download PDF
Document Preview
Document History
  • Publication: Oct 4, 2016
  • Application: May 22, 2014
    US US 201414284524 A
  • Priority: May 22, 2014
    US US 201414284524 A
  • Priority: Dec 17, 2012
    US US 201213716667 A
  • Priority: Jun 14, 2011
    US US 201113160408 A
  • Priority: Mar 31, 2008
    US US 5908608 A
  • Priority: Sep 29, 2006
    IB IB 2006003864 W
  • Priority: Jul 5, 2006
    US US 81831606 P
  • Priority: Oct 12, 2005
    US US 72532005 P
  • Priority: Sep 30, 2005
    FR FR 0510025 A

Sign in to the Lens

Feedback